Emodin regulates apoptotic pathway in human liver cancer cells

Phytotherapy Research

Volumn 27, Issue 2, 2013, Pages 251-257

  Yu, Jian Qing ^a   Bao, Wei ^a   Lei, Jia Chuan ^b  

^a WUHAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Bcl 2; emodin; signaling pathway

Indexed keywords

ALANINE; BH3 PROTEIN; CASPASE 8; CASPASE 9; CYTOCHROME C; EMODIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOACCUMULATION; CANCER CELL; CELL CYCLE G1 PHASE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DIMERIZATION; DOWN REGULATION; DRUG PROTEIN BINDING; ENZYME ACTIVATION; HYDROGEN BOND; LIVER CANCER; MITOCHONDRION; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; WESTERN BLOTTING;

APOPTOSIS; CASPASE 3; CASPASE 9; CELL CYCLE; CYTOCHROMES C; EMODIN; HEP G2 CELLS; HUMANS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84873405972     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4703     Document Type: Article

References (37)

1. Ashkenazi A,. 1998. Death receptors: signaling and modulation. Science 281: 1305-1308.
2. Chipuk JE, Green DR,. 2008. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164.
3. Dave Z, Byfield M, Bossy-Wetzel E,. 2008. Assessing mitochondrial outer embrane permeabilization during apoptosis. Methods 46: 319-323.
4. Finkel T,. 2001. Reactive oxygen species and signal transduction. IUBMB Life 52: 3-6.
5. Frew T, Powis G, Berggren M, et al., 1994. A multiwell assay for inhibitors of phosphatidylinositol 3-kinase and the identification of natural product inhibitors. Anticancer Res 14: 2425-2428.
6. Hafeez BB, Siddiqui IA, Asim M, et al., 2008. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-κB signaling. Cancer Res 68: 8564-8572.
7. Hartwell LH, Kastan MB,. 1994. Cell cycle control and cancer. Science 266: 1821-1828.
8. Hengartner MO,. 2000. The biochemistry of apoptosis. Nature 407: 770-776.
9. Herrmann M,. 1994. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 22: 5506-5507.
10. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ,. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251.
11. Huang Q, Shen HM, Shui G, Wenk MR, Ong CN,. 2006. Emodin inhibits tumor cell adhesion through disruption of the membrane lipid raft-associated integrin signaling pathway. Cancer Res 66: 5807-5815.
12. Huang XZ, Wang J, Huang C, et al., 2008. Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1. Cancer Biol Ther 7: 468-475.
13. Janssen-Heininger YM, Poynter ME, Baeuerle PA,. 2000. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 28: 1317-1327.
14. Jayasuriya H, Koonchanok NM, Geahlen RL, McLaughlin JL, Chang CJ,. 1992. Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. J Nat Prod 55: 696-698.
15. Kroemer G, Reed JC,. 2000. Mitochondrial control of cell death. Nat Med 6: 513-519.
16. Kruse JP, Gu W,. 2009. Modes of p53 regulation. Cell 137: 609-622.
17. Kuwana T, Newmeyer DD,. 2003. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 15: 691-699.
18. Lai JM, Chang JT, Wen CL, Hsu SL,. 2009. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells. Eur J Pharmacol 623: 1-9.
19. McDonald ER, El-Deiry WS,. 2000. Cell cycle control as a basis for cancer drug development. Int J Oncol 16: 871-886.
20. Meier P, Vousden KH,. 2007. Lucifer's labyrinth-ten years of path finding in cell death. Mol Cell 28: 746-754.
21. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J,. 2001. NF-kappa B signals induce the expression of c-FLIP. Mol Cell Biol 21: 5299-5305.
22. Morris GM, Huey R, Lindstrom W, et al., 2009. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. J Comput Chem 30: 2785-2791.
23. Nicholson DW, Thornberry NA,. 1997. Caspases: killer proteases. Trends Biochem Sci 22: 299-306.
24. Owa T, Yoshino H, Yoshimatsu K, Nagasu T,. 2000. Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem 8: 1487-1503.
25. Peter ME,. 1998. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10: 545-551.
26. Reed JC,. 2003. Apoptosis-targeted therapies for cancer. Cancer Cell 3: 17-22.
27. Sauer H, Wartenberg M, Hescheler J,. 2001. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11: 173-186.
28. Scaffidi C,. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687.
29. Schafer B, Quispe J, Choudhary V, et al., 2009. Mitochondrial outer membrane proteins assist Bid in Bax-mediated lipidic pore formation. Mol Biol Cell 20: 2276-2285.
30. Shieh DE, Chen YY, Yen MH, Chiang LC, Lin CC,. 2004. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells. Life Sci 74: 2279-2290.
31. Srinivas G, Anto RJ, Srinivas P, Vidhyalakshmi S, Senan VP, Karunagaran D,. 2003. Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9. Eur J Pharmacol 473: 117-125.
32. Vermeulen K, Berneman ZN, Van Bockstaele DR,. 2003. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 165-175.
33. Wang CY,. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683.
34. Wylli AH, Beattie GJ, Hargreaves AD,. 1981. Chromatin changes in apoptosis. Histochem J 13: 681-692.
35. Yi J, Yang J, He R, et al., 2004. Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res 64: 108-116.
36. Yu JQ, Liu HB, Tian DZ, Liu YW, Lei JC, Zou GL,. 2007. Changes in mitochondrial membrane potential and reactive oxygen species during wogonin- induced cell death in human hepatoma cells. Hepatol Res 37: 68-76.
37. Zhang L, Hung MC,. 1996. Sensitization of HER-2/neuoverexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene 12: 571-576.